Skip to main content
SpringerLink
Log in

Long-acting β-agonists not linked to increased respiratory deaths

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Rodrigo GJ, Nannini LJ, Rodríguez-Roisin R.Safety of long-acting -beta-agonists in stable COPD: a systematic review. Chest 133: 1079-1087, No. 5, May 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Long-acting β-agonists not linked to increased respiratory deaths. React. Wkly. 1202, 1 (2008). https://doi.org/10.2165/00128415-200812020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812020-00001

Keywords

Search

Navigation